BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

872 related articles for article (PubMed ID: 29434445)

  • 1. Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesis.
    El Khodiry A; Afify M; El Tayebi HM
    World J Gastroenterol; 2018 Feb; 24(5):549-572. PubMed ID: 29434445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications.
    Niu ZS; Niu XJ; Wang WH
    World J Gastroenterol; 2017 Aug; 23(32):5860-5874. PubMed ID: 28932078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
    Qiu L; Tang Q; Li G; Chen K
    Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of lncRNAs in hepatocellular carcinoma: opportunities as novel targets for pharmacological intervention.
    Zou H; Shao CX; Zhou QY; Zhu GQ; Shi KQ; Braddock M; Huang DS; Zheng MH
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):331-40. PubMed ID: 26558504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
    Peng W; Fan H
    Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
    He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
    Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress and Prospects of Long Noncoding RNAs (lncRNAs) in Hepatocellular Carcinoma.
    Li C; Chen J; Zhang K; Feng B; Wang R; Chen L
    Cell Physiol Biochem; 2015; 36(2):423-34. PubMed ID: 25968300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
    Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q
    Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of long non-coding RNAs to reveal potential prognostic biomarkers in hepatocellular carcinoma.
    Ma Y; Luo T; Dong D; Wu X; Wang Y
    Gene; 2018 Jul; 663():148-156. PubMed ID: 29684484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNAs: critical players in hepatocellular carcinoma.
    Sun J; Bie B; Zhang S; Yang J; Li Z
    Int J Mol Sci; 2014 Nov; 15(11):20434-48. PubMed ID: 25387074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma.
    Huang JL; Zheng L; Hu YW; Wang Q
    Carcinogenesis; 2014 Mar; 35(3):507-14. PubMed ID: 24296588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel long non-coding RNAs deregulated in hepatocellular carcinoma using RNA-sequencing.
    Esposti DD; Hernandez-Vargas H; Voegele C; Fernandez-Jimenez N; Forey N; Bancel B; Le Calvez-Kelm F; McKay J; Merle P; Herceg Z
    Oncotarget; 2016 May; 7(22):31862-77. PubMed ID: 26887054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNAs are differentially expressed in hepatocellular carcinoma cell lines with differing metastatic potential.
    Fang TT; Sun XJ; Chen J; Zhao Y; Sun RX; Ren N; Liu BB
    Asian Pac J Cancer Prev; 2014; 15(23):10513-24. PubMed ID: 25556502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Long Non-Coding RNAs in Hepatocarcinogenesis.
    Lanzafame M; Bianco G; Terracciano LM; Ng CKY; Piscuoglio S
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
    Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DDX11-AS1 as potential therapy targets for human hepatocellular carcinoma.
    Shi M; Zhang XY; Yu H; Xiang SH; Xu L; Wei J; Wu Q; Jia R; Wang YG; Lu XJ
    Oncotarget; 2017 Jul; 8(27):44195-44202. PubMed ID: 28496001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
    Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
    J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic regulation in hepatocellular carcinoma requires long noncoding RNAs.
    Amicone L; Citarella F; Cicchini C
    Biomed Res Int; 2015; 2015():473942. PubMed ID: 25861629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of long non-coding RNA expression profiles in hepatitis B virus-related hepatocellular carcinoma.
    Gong X; Wei W; Chen L; Xia Z; Yu C
    Oncotarget; 2016 Jul; 7(27):42422-42430. PubMed ID: 27285756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.